Baird’s Model Update Suggests Alignment Healthcare, Inc. (ALHC)’s Shares Could Reach $59

Alignment Healthcare, Inc. (NASDAQ:ALHC) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts.

The next stock on our list is Alignment Healthcare, Inc..

TheFly reported on January 30 that Baird increased its price target on ALHC to $28 from $22 while maintaining an Outperform rating. After updating its financial model, the firm now believes there is significant upside potential and that the shares might rise to $59, or around 163% over their present price.

Separately, John E. Kao, the CEO of Alignment Healthcare, Inc., recently sold 180,000 shares on February 10 for a total of about $3.68 million at a weighted-average price of $20.4853. The individual deals ranged from $20.23 to $20.66. A pre-established Rule 10b5-1 trading plan that was adopted on March 12, 2025, was used to perform the trade.

After the sale, Kao still owns more than 2.6 million shares indirectly through a trust in which he acts as trustee and more than 1.5 million shares personally. The stock has risen 21.7% over the last six months. Despite the company’s lack of profitability over the last 12 months, analysts predict profitability this year, with an expected FY2025 EPS of $0.23. ALHC is also anticipated to report its earnings on February 26, 2026.

Alignment Healthcare, Inc. is a U.S. tech-enabled Medicare Advantage company innovating senior care with AI-driven data analytics through its proprietary AVA platform to proactively predict and personalize care, which is supported by a 24/7 concierge model that improves outcomes, access, and member experience.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street.